Vorbipiprant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vorbipiprant, covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers [Phase 1, Phase 2]